Search Results - "Soloway M"

MP-13.07 Surgical Margin Status is not Associated with Overall Survival After Radical Prostatectomy

Authors: Soloway, M. Manoharan, M. Jorda, M. et al.

Source: Urology. Sep2011 Supplement, Vol. 78, pS126-S126. 1p.

MP-13.06 Complications of Open Radical Prostatectomy: More Than 18 Years Experience at One Center

Authors: Soloway, M. Ji, H. Iremashvili, V. et al.

Source: Urology. Sep2011 Supplement, Vol. 78, pS125-S126. 0p.

POD-07.04 Active Surveillance for Prostate Cancer: An Update on the Miami Experience

Authors: Soloway, M. Manoharan, M. Rosenberg, D. et al.

Source: Urology. Sep2011 Supplement, Vol. 78, pS24-S24. 1p.

POD-07.03 Pathology Results of Radical Prostatectomy in Patients Initially Managed by Active Surveillance

Authors: Soloway, M. Manoharan, M. Jorda, M. et al.

Source: Urology. Sep2011 Supplement, Vol. 78, pS23-S24. 0p.

PD-11.01: Diagnosis and surveillance of bladder cancer using a point-of care proteomic assay

Authors: Grossman, H. Soloway, M.

Source: Urology. Nov2006 Supplement, Vol. 68, p38-38. 1p.

Early ligation of the renal artery using the posterior approach: a basic surgical concept reinforced during resection of large hypervascular renal cell carcinoma with or without inferior vena cava thrombus.

Authors: Ciancio, G. Vaidya, A. Soloway, M.

Source: BJU International. Sep2003, Vol. 92 Issue 4, p488. 2p.

Active surveillance for low-risk prostate cancer: knowledge, acceptance and practice among urologists.

Authors: Gorin, M A Eldefrawy, A Ekwenna, O et al.

Source: Prostate Cancer & Prostatic Diseases. Jun2012, Vol. 15 Issue 2, p177-181. 5p.

Comparison of urologist reimbursement for managing patients with low-risk prostate cancer by active surveillance versus total prostatectomy.

Authors: Manoharan, M. Eldefrawy, A. Katkoori, D. et al.

Source: Prostate Cancer & Prostatic Diseases. 2010, Vol. 13 Issue 4, p307-310. 4p. 1 Chart, 2 Graphs.

Modified Pfannenstiel approach for radical retropubic prostatectomy: a 3-year experience.

Authors: Manoharan, M. Ayyathurai, R. Nieder, A. M. et al.

Source: Prostate Cancer & Prostatic Diseases. 2008, Vol. 11 Issue 1, p74-78. 5p. 1 Black and White Photograph, 1 Diagram, 5 Charts.

Hemospermia following transrectal ultrasound-guided prostate biopsy: a prospective study.

Authors: Manoharan, M Ayyathurai, R Nieder, A M et al.

Source: Prostate Cancer & Prostatic Diseases. 2007, Vol. 10 Issue 3, p283-287. 5p. 2 Charts.

A0742 - The international bladder cancer group intermediate-risk non-muscle invasive bladder cancer (IBCG IR-NMIBC) scoring system predicts the need for intervention for patients on active surveillance.

Authors: Contieri, R. Tan, W.S. Buffi, N.M. et al.

Source: European Urology. 2024 Supplement 1, Vol. 85, pS1717-S1717. 1p.

Independent prognostic factors in patients with metastatic (stage D2) prostate cancer. The Zoladex Study Group.

Authors: Chodak, G W Vogelzang, N J Caplan, R J et al.

Source: JAMA: Journal of the American Medical Association. 2/6/91, Vol. 265 Issue 5, p618-621. 4p.

The role of radical prostatectomy in patients with PSA of 20 or greater and/or a prostate biopsy with a total Gleason sum of 8 or greater.

Authors: Bird, V G Vaidya, A Tiguert, R et al.

Source: Prostate Cancer & Prostatic Diseases. 2000 Supplement 1, Vol. 3 Issue 4, pS6. 1p.

957 Long-term reduction in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy

Authors: Burger, M. Stenzl, A. Mynderse, L. et al.

Source: European Urology Supplements. Feb2012, Vol. 11 Issue 1, pe957-e957a. 2p.

85 - SLC13A3 as a functional biomarker and determinant of racial discrepancies in renal cell carcinoma.

Authors: Hennig, M. Jordan, A. Kramer, M. et al.

Source: European Urology Supplements. Mar2018, Vol. 17 Issue 2, pe123-e123. 1p.

Exploration of isoform switching and mutation expression in breast cancer by mRNA-sequencing analysis.

Authors: Hoadley, K. A. Parker, J. S. Wilkerson, M. D. et al.

Source: Cancer Research. Dec2012 Meeting Abstracts, Vol. 72 Issue 24a, p2231-2231. 1p.

Dynamic Contrast Enhanced MRI for the Identification of Prostate Cancer in the Prostate Bed After Radical Prostatectomy

Authors: Abramowitz, M.C. Stoyanova, R. Kava, B. et al.

Source: International Journal of Radiation Oncology, Biology, Physics. Oct2011 Supplement, Vol. 81 Issue 2, pS410-S410. 1p.

POD-07.01: Hexaminolevulinate New Data: Results from the Recurrence Study

Authors: Grossman, H.B. Mynderse, L. Stenzl, A. et al.

Source: Urology. Oct2009 Supplement, Vol. 74, pS20-S21. 0p.

656 A MULTI-INSTITUTIONAL COHORT OF ACTIVE SURVEILLANCE FOR LOW-RISK LOCALIZED PROSTATE CANCER

Authors: Eggener, S. Berglund, R. Mueller, A. et al.

Source: European Urology Supplements. Mar2008, Vol. 7 Issue 3, p235-235. 1p.

383 HYALURONIC ACID AND HYAL1 HYALURONIDASE: PROGNOSTIC MARKERS FOR BLADDER CANCER

Authors: Kramer, M.W. Golshani, R. Merseburger, A.S. et al.

Source: European Urology Supplements. Feb2007, Vol. 6 Issue 2, p118-118. 1p.